StockNews.com started coverage on shares of Senseonics (NYSE:SENS – Free Report) in a research note published on Thursday. The firm issued a sell rating on the stock.
Senseonics Price Performance
SENS stock opened at $0.48 on Thursday. The firm has a 50 day moving average price of $0.43 and a 200-day moving average price of $0.51. Senseonics has a 52-week low of $0.37 and a 52-week high of $1.05. The firm has a market capitalization of $252.17 million, a price-to-earnings ratio of -3.39 and a beta of 0.82. The company has a debt-to-equity ratio of 1.79, a quick ratio of 3.70 and a current ratio of 3.96.
Senseonics (NYSE:SENS – Get Free Report) last released its earnings results on Monday, May 13th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). Senseonics had a negative net margin of 346.38% and a negative return on equity of 202.32%. The firm had revenue of $5.05 million during the quarter, compared to analyst estimates of $4.76 million. Equities research analysts forecast that Senseonics will post -0.12 EPS for the current fiscal year.
Institutional Investors Weigh In On Senseonics
About Senseonics
Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.
Read More
- Five stocks we like better than Senseonics
- What is Insider Trading? What You Can Learn from Insider Trading
- Top 3 Defense Stocks That Should Be on Your Radar
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.